AstraZeneca | Investor Conference Presentation Deck | 26 slides · page 17 of 26
The slide uses a split layout: left side details specific drug assets (anselamimab, ALXN2220) with clinical stage data, right side outlines the genomic medicine strategy.
Conference presentation · key_messages · present_solution · dense density
Slide locked Sign in to view
Slide schematic 6/6
image 1/1 metric 1/1 source-note 1/1 table 1/1 title 2/2
Components 6
icon-grid big-number source-note data action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.